Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis

Area of Science:

• Biomedical research
• Vascular biology
• Oncology

Background:

• Angiostatic therapies aim to inhibit pathological neovascularization but have limited success.
• Complete inhibition of neovascular growth remains a challenge in treating various diseases.

Purpose of the Study:

• To investigate the synergistic effects of combining angiostatic molecules targeting distinct angiogenic pathways.
• To evaluate the efficacy of combination angiostatic therapy in inhibiting pathological neovascularization and its impact on tumor growth.

Main Methods:

• Combination therapy using angiostatic molecules targeting different aspects of angiogenesis.
• Assessment of neovascular growth inhibition in models of development, ischemic retinopathy, and tumor growth.
• Evaluation of tumor mass, survival rates, and compensatory proangiogenic factor up-regulation in a rat 9L gliosarcoma model.

Main Results:

• Combination therapy achieved complete inhibition of neovascular growth in multiple pathological conditions.
• Tumor vascular obliteration with combination therapy reduced tumor mass and increased survival in a rat gliosarcoma model.
• Combination therapy significantly reduced compensatory up-regulation of proangiogenic factors, unlike monotherapies.

Conclusions:

• Synergistic combination of angiostatic molecules targeting distinct angiogenic processes offers a novel therapeutic paradigm.
• This approach effectively inhibits pathological neovascularization with minimal impact on normal vasculature.
• Combination angiostatic therapy presents a promising strategy for treating diseases associated with pathological neovascularization.